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Abstract 
Introduction 
Secondary bladder neoplasms are uncommon and they represent only 2% of all malignant 
bladder tumors. 
Case presentation 
The authors present a case of a 59-year-old Caucasian man with a primary gastric 
adenocarcinoma that had been surgically removed 10 years before he developed bladder 
metastasis. He presented with low abdominal pain after 10 years without any symptoms. 
Cystoscopy and an abdominal computed tomography scan showed a bladder tumor. A 
transurethral resection of the bladder tumor was performed. A histological examination 
revealed an adenocarcinoma, which turned out to be a metastasis of the primary gastric 
tumor. One year later, abdominal surgery revealed peritoneal metastases. 
Conclusion 
This is the first known case in Europe where bladder metastasis occurred 10 years after 
surgical removal of a primary gastric neoplasm. There are only four cases in the literature 
where metastases of the peritoneum developed 11 years after surgical removal of a primary 
gastric tumor. 
Keywords 
Gastric tumor, Bladder adenocarcinoma, Secondary bladder cancer, Secondary peritoneal 
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Introduction 
Bladder tumor is the eighth most common neoplasm in Hungary (the fifteenth most common 
in women and the sixth most common in men) [1]. More than 95% of primary bladder tumors 
are transition cell carcinomas, while approximately 1% is adenocarcinoma. Secondary 
bladder neoplasms are uncommon and they represent only 2% of all malignant bladder 
tumors. Secondary bladder neoplasms usually arise from a primary colon, prostatic, or 
cervical tumor or from organs surrounding the bladder itself. Metastases usually originate 
from gastric or breast neoplasms, and melanoma. Krukenberg metastasis of a gastric tumor in 
women (an ovarian metastasis from a gastric neoplasm) could be a direct source of a 
secondary bladder malignancy. Symptoms appear in approximately 20% of metastatic cases, 
while the majority of cases remain asymptomatic and only autopsy reveals vesical 
involvement. As primary adenocarcinoma of the bladder is rare, when a tumor is found, it 
should alert the clinician for a possible metastatic origin; therefore, further investigations 
should be carried out to find the primary tumor. In publications where bladder metastasis 
originated from a primary gastric neoplasm, secondary malignancy occurred within two years 
after the diagnosis of the primary tumor. Most of these cases were reported from Japan [2-9]. 
Only a few cases were published where a secondary tumor occurred 10 years after the 
surgical removal of a primary gastric neoplasm [10]. Gastric neoplasms usually metastasize 
into the liver, lung, abdominal lymph nodes, bones and the peritoneum. Bladder metastasis 
usually occurs after the primary tumor has become widespread with peritoneal metastases. A 
solitary bladder metastasis is extremely rare. 
We report a single case in a man with late urinary bladder metastasis 10 years after the 
surgical removal of the primary gastric adenocarcinoma. 
Case presentation 
A 59-year-old Caucasian man presented to his doctor with gastric complaints. Gastroscopy 
showed an ulcer with a diameter of 5cm along the lesser curvature in the prepyloric antrum. 
A biopsy revealed adenocarcinoma of the stomach. The patient underwent a Billroth II 
resection of the stomach, omentectomy and D2 lymph node dissection. An anatomical 
preparation showed an exulcerated and infiltrative tumor invading all layers of the stomach 
(Figure 1). Histopathologic evaluation revealed well-differentiated exulcerated 
adenocarcinoma with highly desmoplastic stroma and malignant cells arranged in solid nests 
and glands with mucin production at TNM stage III, pT3, pN2. Eight out of 18 removed 
perigastric lymph nodes showed metastatic foci. Lymphatic vessel involvement was 
observed. According to Lauren's classification, this tumor was an intestinal type with low 
proliferative fraction, in World Health Organization (WHO) classification, it was tubular 
adenocarcinoma. Only 2 to 3% of tumor cells were molecular immunology Borstel-1 
(MIB1)+, which justified its slow runoff. Abdominal and chest computed tomography (CT) 
scans did not show distant metastasis. The patient was treated with six cycles of cisplatin and 
VePesid® (etoposide) chemotherapy after surgery. We did not observe any sign of local 
recurrence or distant metastasis during follow-up. Our patient was admitted again with low 
abdominal pain and discomfort 10 years after the gastric tumor diagnosis. Ultrasound showed 
a 2x4cm unidentified mass on the left posterior wall of the bladder. A CT scan detected a 
tumor-like mass on the left side of the bladder. Cystoscopy revealed mucosal hyperemia and 
a tumor close to the left ureteric orifice. We did not detect any other malignancies neither in 
the thorax, nor in other parts of the abdomen. A transurethral resection of the left-sided 
bladder tumor was performed. A pathologic examination described mucosal inflammation, 
intact epithelium, local diffuse muscle invasion (especially in the outer muscular layers), a 
connective tissue-rich stroma and atypical glandular proliferation with atypical simple 
columnar-cuboidal epithelium (Figure 2). 
Figure 1 (a) Histopathology of the stomach representing adenocarcinoma of the 
stomach involving all the layers of the stomach wall (hematoxylin and eosin ×20). (b) 
tumor cells in the subserous lymphoid vessels (hematoxylin and eosin ×200). 
Figure 2 (a) Bladder biopsy specimen showing well-differentiated tubular 
adenocarcinoma (hematoxylin and eosin ×40). (b) with higher magnification 
(hematoxylin and eosin ×200). 
Immunohistochemical staining of tumor cells detected epithelial membrane antigen (EMA)+, 
cytokeratin (CK)7+, CA19.9 +, CK20-, carcinoembryonic antigen (CEA)+, while prostate-
specific antigen (PSA) was irrelevant. Because of its EMA positivity and CK20 negativity 
this urinary bladder tumor turned out to be secondary to a gastric neoplasm. Endoscopic 
control of the primary gastric tumor was performed after a pathologic examination, and a 
biopsy from the scar showed no sign of local recurrence. Positron emission tomography - 
computed tomography (PET-CT) presented residual malignancy in the bladder. Cystoscopy 
showed mucosal hyperemia and edema on the left lower part of the posterior wall and 
necrosis on its surface. The patient received five cycles of epirubicin, cisplatin and 
capecitabine (ECX) chemotherapy. He responded well to treatment and control PET and CT 
scans were negative. He became asymptomatic. One year later, a colonoscopy detected a 4cm 
sessile polyp in the ascending colon. A histopathologic evaluation revealed adenoma with 
high-grade dysplasia. An exploratory laparotomy was performed and, surprisingly, peritoneal 
dissemination was found. A histopathological examination proved metastases of the primary 
gastric neoplasm for a second time (Figure 3). The tumor was CK7+ and CEA+, CK20-, 
CA19.9 +, caudal-type homeobox transcription factor (CDX)-2-, thyroid transcription factor 
(TTF)-1-. The surgical specimens were formalin-fixed. Paraffin-embedded sections (5µm) 
were used for conventional light microscopy. Silane-coated glass slides and 4µm thick 
sections were used for immunohistochemistry with antigen retrieval. The following 
commercially available antibodies were used, according to the manufacturers’ 
recommendations. 
Figure 3 Histopathology of the peritoneum, presenting adenocarcinoma (hematoxylin 
and eosin ×200). 
Antibodies: CK7: (Dako, Glostrup, Denmark, OV-TL-12/30, 1:100), Ki67: (Dako, MIB-1, 
1:100), EMA: (Dako, E29, 1:100), CEA: (Dako, II-7, 1:50), CK20: (Dako, KS20.8; 1:50), 
CDX-2: (Novocastra, Leica Microsystems, Wetzlar, Germany, AMT28, 1:50), CA19.9: 
(Novocastra, Leica Microsystems, Wetzlar, Germany, C241, 1:100), TTF-1: (Dako, 
8G7G3/1, 1:50), PSA: (Dako, polyclonal, 1:1000). 
Discussion 
Bladder metastases are rare and represent only 2% of all bladder tumors. Metastases to 
urinary bladder could not only originate from the direct spread of a primary tumor, but also 
from implantation of detached pelvic/ureteric neoplastic cells, lymphogenic/hematogenous or 
even peritoneal dissemination from a distant primary neoplasm. Gastrointestinal origin is 
suspected if a biopsy reveals signet-ring cell adenocarcinoma [7,9]. A primary bladder 
adenocarcinoma is a very rare tumor. Some 282 secondary bladder tumors were analyzed at 
Royal Marsden Hospital, which represented only 2.3% of all bladder neoplasms examined by 
them. The localizations of the primary tumor were the following: 21% originated from the 
colon, 19% had a prostatic origin, 12% originated from the rectum and 11% from the cervix. 
In the cases mentioned above a direct spread of a primary neoplasm caused a bladder 
metastasis. In 4.3% of all cases they found a primary gastric carcinoma, 96.7% were solitary 
metastasis located in the trigone or in the neck of the bladder. A total of 54% of cases were 
adenocarcinoma [11]. 
In our case, the metastatic tumor in the bladder occurred 10 years after the primary neoplasm. 
Surgical intervention was decided, as we could not detect any metastasis elsewhere and could 
not prove local recurrence in the stomach. The literature suggests chemotherapy in case of 
multiple metastases. We first diagnosed bladder metastasis and one year later peritoneal 
metastases. During the redactation of present article the patient was still alive. Peritoneal 
metastases can be detected in only 17% of gastric carcinomas [12], which could be caused by 
direct serosal spread, lymphogenic or vascular dissemination. Overall survival after 
peritoneal metastases is usually less than six months. 
There are only four cases in the literature where peritoneal metastases occurred 10 years after 
resection of a primary neoplasm. Two cases were reported from Japan, two reports from 
Korea, but none from Europe. In all four cases, serosal surfaces and lymph nodes were also 
histologically affected. In these cases, peritoneal metastases occurred within five years after 
surgery but a 10-year interval for metastasis manifestation is very rare [13-15]. 
Conclusion 
The authors presented a rare case where, 10 years after the surgical removal of a primary 
gastric neoplasm, first a bladder and a year later peritoneal metastases occurred. This is the 
first known case in Europe where, more than 10 years after surgical removal of the primary 
gastric neoplasm, vesical and peritoneal metastases occurred. In a case of bladder 
adenocarcinoma, one should always think of the possibility of metastasis, even years after 
surgical removal of a primary neoplasm. In a case of an unknown primary tumor, further 
investigations are advised in order to find a possible source of the metastasis. As a solitary 
bladder metastasis of gastric cancer is rare, one should always search for peritoneal 
involvement as well. In our case, one year after the diagnosis of a bladder metastasis 
peritoneal metastases were found during abdominal surgery. Imaging techniques showed no 
sign of peritoneal involvement. All of the three surgical specimens (stomach, bladder, and 
peritoneum) contained the same histopathologic type of tumor. 
With our case presentation, we would like to stress the necessity at routine disease control to 
search for distant metastases even 10 years after the primary intervention. 
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